First Approved Alexander Disease Treatment Arrives with a List Price Above One Million Dollars Per Year

FDA approved Zanvastro for Alexander disease. Ionis set the list price at $285,000 per dose, or about $1.14 million a year at quarterly dosing.

Have A Referral?